The site is undergoing maintenance. Ordering can continue through fax and phone.
Sunday, August 16, 2026, 1:30 - 4:30 pm (CEST).
If you encounter problems while ordering. Please contact us at BDBCustomerService@bd.com
See More
The site is undergoing maintenance. Ordering can continue through fax and phone.
Sunday, August 16, 2026, 1:30 - 4:30 pm (CEST).
If you encounter problems while ordering. Please contact us at BDBCustomerService@bd.com
See MoreThe site is undergoing maintenance. Ordering can continue through fax and phone.
Sunday, August 16, 2026, 1:30 - 4:30 pm (CEST)
.If you encounter problems while ordering. Please contact us at BDBCustomerService@bd.com
This page has been recently translated and is available in French now.
Looks like you're visiting us from {countryName}.
Would you like to stay on the current location site or be switched to your location?
Expression of CD44 on bone-marrow myeloid cells. Mouse bone-marrow leukocytes were stained with either V450 Rat IgG2b, κ isotype control mAb A95-1 (Cat. no. 560457, left panel) or V450 Rat anti-Mouse CD44 mAb IM7 (Cat. no. 560451/560452, right panel). Flow cytometry was performed on a BD™ LSR II flow cytometry system.
Expression of CD44 on bone-marrow myeloid cells. Mouse bone-marrow leukocytes were stained with either V450 Rat IgG2b, κ isotype control mAb A95-1 (Cat. no. 560457, left panel) or V450 Rat anti-Mouse CD44 mAb IM7 (Cat. no. 560451/560452, right panel). Flow cytometry was performed on a BD™ LSR II flow cytometry system.
Expression of CD44 on bone-marrow myeloid cells. Mouse bone-marrow leukocytes were stained with either V450 Rat IgG2b, κ isotype control mAb A95-1 (Cat. no. 560457, left panel) or V450 Rat anti-Mouse CD44 mAb IM7 (Cat. no. 560451/560452, right panel). Flow cytometry was performed on a BD™ LSR II flow cytometry system.
Expression of CD44 on bone-marrow myeloid cells. Mouse bone-marrow leukocytes were stained with either V450 Rat IgG2b, κ isotype control mAb A95-1 (Cat. no. 560457, left panel) or V450 Rat anti-Mouse CD44 mAb IM7 (Cat. no. 560451/560452, right panel). Flow cytometry was performed on a BD™ LSR II flow cytometry system.
Expression of CD44 on bone-marrow myeloid cells. Mouse bone-marrow leukocytes were stained with either V450 Rat IgG2b, κ isotype control mAb A95-1 (Cat. no. 560457, left panel) or V450 Rat anti-Mouse CD44 mAb IM7 (Cat. no. 560451/560452, right panel). Flow cytometry was performed on a BD™ LSR II flow cytometry system.
Expression of CD44 on bone-marrow myeloid cells. Mouse bone-marrow leukocytes were stained with either V450 Rat IgG2b, κ isotype control mAb A95-1 (Cat. no. 560457, left panel) or V450 Rat anti-Mouse CD44 mAb IM7 (Cat. no. 560451/560452, right panel). Flow cytometry was performed on a BD™ LSR II flow cytometry system.
Any use of products other than the permitted use without the express written authorization of Becton, Dickinson and Company is strictly prohibited.
The IM7 antibody specifically recognizes an epitope on both alloantigens and all isoforms of the CD44 glycoprotein (Pgp-1, Ly-24). The standard form of CD44, lacking variable exons and referred to as CD44H or CD44s, is widely expressed on hematopoietic and non-hematopoietic cells. CD44 isoforms encoded by variable exons are expressed on epithelial cells, but only at low levels on most leukocytes. Mice with the Ly-24.1 alloantigen (e.g., BALB/c, CBA/J, DBA/1, DBA/2) have relatively large subsets of CD44H+ T lymphocytes, while Ly-24.2 strains (e.g., A, AKR, CBA/N, C3H/He, C57BL, C57BR, C57L, C58, NZB, SJL, SWR, 129) have fewer CD44H+ T cells. CD44 is a cell adhesion receptor, and its principal ligand, hyaluronate, is a common component of extracellular matrices. Differential glycosylation of CD44 influences its binding to hyaluronate. Additional ligands include the cell surface form of CD74 and the cytokine osteopontin (Eta-1). Bone marrow- and thymus-derived progenitor cells capable of repopulating the thymus express CD44. In the periphery, the level of CD44 expression increases upon activation of B lymphocytes, CD4+ T cells, and CD8+ T cells; memory cells can be recognized by their CD44[hi] phenotype. The IM7 mAb inhibits established collagen-induced arthritis in DBA/1 mice. Moreover, it prevents CNS inflammation and clinical symptoms of experimental autoimmune encephalomyelitis. In contrast, the same antibody exacerbates experimental autoimmune thyroiditis in CBA/J mice. The IM7 mAb recognizes a different epitope from that recognized by mAb KM114, and the antibody pair can be used in ELISA to detect soluble CD44. It has been observed that IM7 antibody crossreacts with human, dog, cat, horse, cow, and pig leukocytes. Anti-human CD44, clone G44-26, and IM7 antibody compete for binding to human peripheral blood lymphocytes.
The antibody is conjugated to BD Horizon™ V450, which has been developed for use in multicolor flow cytometry experiments and is available exclusively from BD Biosciences. It is excited by the Violet laser Ex max of 406 nm and has an Em Max at 450 nm. Conjugates with BD Horizon™ V450 can be used in place of Pacific Blue™ conjugates.
Please refer to Support Documents for Quality Certificates
Global - Refer to manufacturer's instructions for use and related User Manuals and Technical data sheets before using this products as described
Comparisons, where applicable, are made against older BD Technology, manual methods or are general performance claims. Comparisons are not made against non-BD technologies, unless otherwise noted.
For Research Use Only. Not for use in diagnostic or therapeutic procedures.